3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
2
Other neoplasm
1
Conditions
Precancerous Conditions
1
Neoplasms
1
Keratosis, Actinic
1
Keratosis
1
Interventions
fludarabine
2
Taxes
2
Specimen Handling
2
Paclitaxel
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Educational Status
2
Aminolevulinic Acid
2
venetoclax
1
tirbanibulin
1
taxane
1
radium Ra 223 dichloride
1
fludarabine phosphate
1
abemaciclib
1
X-Rays
1
Whole-Body Irradiation
1
Tamoxifen
1
Tacrolimus
1
Surveys and Questionnaires
1
Robotic Surgical Procedures
1
Resistance Training
1
Radiotherapy
1
Platinum
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Morphine
1
Methods
1
Mesna
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
tirbanibulin
×
Other neoplasm
×
90 days
×
Clear all
NCT06135415
2026-03-25
TirbAKare
Almirall, S.A.
Phase 3
Completed
280 enrolled